PO.EN01.01 · 内分泌肿瘤
接触塑料添加剂提示前列腺癌中潜在的雄激素受体激动作用
Exposure to plastic additives suggests potential androgen receptor agonism in prostate cancer
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:塑料是世界上最丰富的人造物质,日常摄入构成全球公共健康威胁。塑料由固态碳氢聚合物构成,含有超过10,000种增强塑料材料特性的化学"添加剂"。这些添加剂包括已知致癌物、内分泌干扰化合物和DNA损伤剂。内分泌干扰物尤其令人担忧,因为它们可能促进激素依赖性癌症的生长或抑制治疗中使用的激素疗法。或许更令人警惕的是,我们对尚未表征的数千种添加剂知之甚少。在此,我们开发了一个计算平台,以识别对雄激素受体(AR,前列腺癌生长信号传导所使用的关键激素受体)具有潜在结合活性的添加剂。这项工作的目标是更好地理解这些日常接触如何可能影响内分泌信号传导,并潜在地助长前列腺癌的生长。
方法:我们开发了一个成对深度学习模型,通过利用化合物间的相对效能关系来提高AR激动剂预测的准确性。在469个化合物结构和半数最大有效浓度(EC50)值上训练该模型后,我们筛选了2,712种塑料添加剂,并鉴定出八种常用添加剂为潜在的AR激动剂。我们用每种添加剂处理经工程改造带有荧光前列腺特异性抗原(PSA)报告基因的AR依赖性LNCaP细胞,浓度范围为100 μM至0.0001 μM。使用Incucyte S3®(Sartorius)的分析功能量化细胞生长速率和通过PSA报告基因反映的AR活性。
结果:在对深度学习模型的预测候选物进行排序后,我们基于良好的预测值、成本和可获得性选择了八种化合物进行实验验证。在最初筛选的七种添加剂中,四种在10 μM添加剂暴露时显示PSA报告基因表达显著增加(乙二胺四乙酸、癸二酸、2,4,6-三溴苯酚和TTBP-TAZ)。两种添加剂(TTBP-TAZ和2,4,6-三溴苯酚)在1-100 μM剂量范围内显示显著的生长增殖。将这些添加剂与人类生物监测数据交叉核对显示,十溴二苯醚和2,4,6-三溴苯酚已在人类样本中被检出,并正被监测以进行潜在检测。
结论:我们开发并部署了一种成对深度学习方法,以筛选塑料添加剂数据库中预测的AR活性,并通过实验验证了其中三种添加剂的AR激活。这项工作有助于识别接触AR激动剂的环境暴露区域,这些暴露会增加前列腺癌发生或进展的风险。未来工作重点是扩展该平台以识别作为与癌症相关的其他激素调节剂的化合物,并开发在患者样本中检测这些添加剂的检测方法。
查看英文原文 English abstract
Introduction: Plastic is the most abundant human-made substance in the world, and routine ingestion represents a global public health threat. Plastics are comprised of solid hydrocarbon polymers with over 10,000 chemical “additives” that augment the material properties of plastic. These additives include known carcinogens, endocrine disrupting compounds, and DNA damaging agents. Endocrine disruptors are of particular concern, as they may promote growth of hormone-dependent cancers or inhibit hormone therapies used in treatment. Perhaps more alarming is how little we know about the thousands of additives not yet characterized. Here we developed a computational platform to identify additives with potential binding activity to androgen receptor (AR), the key hormone receptor used for prostate cancer growth signaling. The goal for this work is to better understand how these routine exposures may impact endocrine signaling and potentially fuel prostate cancer growth.
Methods: We developed a pairwise deep learning model to enhance AR agonist prediction accuracy by leveraging relative potency relationships among compounds. After training this model on 469 compound structures and half-maximal effective concentration (EC 50 ) values, we screened 2,712 plastic additives and identified eight commonly used additives as potential AR agonists. We treated AR-dependent LNCaP cells engineered with a fluorescent prostate-specific antigen (PSA) reporter with each additive, ranging from 100 µM to 0.0001 µM. Cell growth rate and AR activity via PSA reporter were quantified using the analysis features on the Incucyte S3® (Sartorius).
Results: Upon ranking predicted candidates from our deep learning model, we selected eight compounds for experimental validation based on favorable prediction values, cost, and availability. Out of seven additives initially screened, four showed significant increases in PSA reporter expression upon additive exposure at 10 µM (edetic acid, sebacic acid, 2,4,6-tribromophenol, and TTBP-TAZ). Two additives (TTBP-TAZ and 2,4,6-tribromophenol) showed significant growth proliferation at doses ranging from 1-100 µM. Cross-checking these additives with human biomonitoring data shows that decabromodiphenyl ether and 2,4,6-triboromophenol have been detected in human samples and are being monitored for potential detection.
Conclusions: We have developed and deployed a pairwise deep learning approach to screen a database of plastic additives for predicted AR activity and validated experimentally the AR activation for three of these additives. This work could help identify areas of environmental exposure to AR agonists that increase risk of prostate cancer development or progression. Future work is focused on expanding this platform to identify compounds acting as regulators of other hormones relevant in cancer and developing assays to detect these additives in patient samples.
利益披露 Disclosure
W. K. Watlington, None..
S. Colmenares, None..
J. Carter, None..
S. Vincoff, None..
A. A. Armstrong, None..
D. Reker, None..
J. A. Somarelli, None.